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ABSTRACT 
 
The aim of the present study was to synthesize a series of new lignans intermediates as antimicrobial inhibition 
agents were synthesized by a simple procedure. The cyclocondensation reaction of (Z)-3-(ethoxycarbonyl)-4,4-
(diaryl)but-3-enoic acids, 1(a-d) with acetic anhydride in glacial acetic acid produced Ethyl 4-acetoxy-1-aryl-2-
naphthoates 2(a-d) and with polyphosphosphoric acid yielded ethyl 1-aryl-4-hydroxy-2-naphthoates 4(a-d) in good 
yields. The synthesized compounds were evaluated for their antimicrobial activity. The new compounds were 
characterized by IR, 1H NMR, 13C NMR, MS studies and elemental analysis. Results of antimicrobial activity reveal 
that some of the synthesized compounds act as potential antimicrobial agents different fungal and bacterial 
organisms. 
 
Key words: Acetic anhydride, antimicrobial, cyclization, inhibition, PPA. 
_____________________________________________________________________________________________ 
 
INTRODUCTION 
 
The lignans are a group of secondary metabolites found in plants produced by oxidative dimerization of two 
phenylpropanoid units. Lignans are known to have anti-tumour, antimitotic and antiviral activity and to specifically 
inhibit certain enzymes. New lignans continue to be described by natural products chemists at a steady rate and 
knowledge of their variety is continually expanding [1]. Thiophene-based lignan analogues were synthesized by a 
selective and high performance synthetic strategy based on the Negishi cross-coupling reaction [2]. An 
enantiomerically pure α-hydroxylated lactone lignans were synthesized from diisopropyl malate involving 
stereoselective alkylation followed by saponification and acetalization [3]. 
 
1-Phenyl-1H-benzo[b]azepine-2,5-dione prepared by an intramolecular cyclisation of  4-N,N-diphenylamine-4-oxo-
2-butenoic acid showed considerable activity against F. Solani and A. Flavus fungal strains [4]. A recent review on 
lignans describes the different synthetic strategies adopted for the synthesis of lignans [5]. Monica et al [6] reported 
an asymmetric and regioselective total synthesis approach to 1,4-benzodioxane lignans in which (2R,3R)- and 
(2S,3S)-3-(4-hydroxy-3-methoxyphenyl)-2-hydroxymethyl-1,4-benzodioxan-6-carbaldehydes. l-Aryl-2-methyl-
tetrahydronaphthoic acid anhydride reacts with stabilized phosphorus ylide exclusively to the carbonyl remote from 
the 1-aryl substituent and has been converted into a variety of compounds related in structure to 
deoxyisopicrophyllotoxin [7].  
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A series of new lignans ethyl 4-acetoxy-6-ethoxy-1-(4-aryl)-2-naphthoates and ethyl 1-aryl-6-ethoxy-4-hydroxy-2-
naphthoates were synthesized by simple and accessible procedure involving cyclocondensation reaction of 3-
(ethoxycarbonyl)-4,4-(diaryl)but-3-enoic acids with acetic anhydride in glacial acetic acid and with 
polyphosphosphoric acid respectively. The synthesized compounds showed antimicrobial inhibitory effect [8]. In 
view of diverse applications of lignan analogues, we herein report the synthesis of lignan intermediates and their 
antimicrobial inhibition activity studies.  
 
EXPERIMENTAL SECTION 
 
In a typical procedure, 4-diaryl-3- ethoxycarbonyl-but-3-enoic acids1(a-d) were subjected to cyclisation reaction 
with acetic anhydride in the presence of sodium acetate to get Ethyl 4-acetoxy-6-ethoxy-1-(4-aryl)-2-naphthoates, 
2(a-d) in good yields. On the other hand, 1(a-d) on cyclisation reaction with PPA at 90-100 ºC afforded ethyl 6-
ethoxy-1-(4-aryl)-4-oxo-3,4-dihydronaphthalene-2-carboxylates, 3(a-d) which undergo tautomerization to form 4(a-
d) in good yields  (Scheme1). 
 
 
 
(Z)-3-(Ethoxycarbonyl)-4-(4-ethoxyphenyl)-4-(4-methoxyphenyl)but-3-enoic acid, 1a reacted with acetic anhydride 
in the presence of a mild base sodium acetate to form a cyclic intermediate ethyl 1-(4-ethoxyphenyl)-6-methoxy-4-
oxo-3,4-dihydronaphthalene-2-carboxylate, which rapidly undergo tautomerization to form more stable aromatized 
ethyl 1-(4-ethoxyphenyl)-4-hydroxy-6-methoxy-2-naphthoate, which reacted with excess of acetic anhydride to 
form  Ethyl 4-acetoxy-1-(4-ethoxyphenyl)-6-methoxy-2-naphthoate, 2a in good yield (Scheme 2). 
 
On the other hand (Z)-3-(Ethoxycarbonyl)-4-(4-ethoxyphenyl)-4-(4-methoxyphenyl)but-3-enoic acid, 1a reacted 
with polyphosphoric acid (PPA) under reflux conditions to form a cyclic intermediate ethyl 1-(4-ethoxyphenyl)-6-
methoxy-4-oxo-3,4-dihydronaphthalene-2-carboxylate 3a, which was not isolated. The compound 3a rapidly 
undergo tautomerization to form more stable aromatized ethyl 1-(4-ethoxyphenyl)-4-hydroxy-6-methoxy-2-
naphthoate 4a in good yield. The absence of cyclic C=O str band and a sharp absorption band at γ 3615 cm-1 for OH 
str in the IR spectra of the isolated product confirms the formation of 4a. 
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Scheme-2: Proposed mechanism for the formation of 2a
 
 
Materials and methods 
Melting points were determined by open capillary method and are uncorrected. IR spectra were recorded on a Nujol 
mull on Shimadzu 8300 spectrometer.1H NMR and 13C NMR spectra were recorded on Agilent-NMR 400 MHz and 
100 MHz spectrophotometer respectively in CDCl3 with TMS as an internal standard. The chemical shifts are 
expressed in δ ppm. Mass spectra were obtained on Mass Lynx SCN781 spectrophotomer TOF mode. Elemental 
analysis was performed on a Thermo Finnigan Flash EA 1112 CHN analyzer. Chromatographic separations were 
carried out on silica gel (70-230 mesh, Merck) column using hexane: ethyl acetate (6:2 v/v) as eluent. 
 
4.1. Preparation of polyphosphoric acid (PPA): Initially reagent grade orhopolyphosphoric acid (85 mL) was 
heated for half an hour to remove traces of water present in it. Phosphorous pentoxide (100g) was taken in a 250 mL 
three-necked flask and then the flask equipped with a mechanical stirrer, mercury seal tube and guard tube. The hot 
orhopolyphosphoric acid (75 mL) was added to phosphorous pentoxide and the mixture was vigorously stirred by 
maintaining the temperature between 170-200 ºC. The whole mixture became a clear viscous liquid. The solid lump 
left over was removed by means of a spatula and the liquid was stirred for again for 1 hr and cooled to 90-100 ºC. 
 
4.2. General procedure for the synthesis of Ethyl 4-acetoxy-1-aryl-2-naphthoates, 2(a-d): A solution of (Z)-3-
(ethoxycarbonyl)-4,4-(diaryl)but-3-enoic acids, 1(a-d) (0.005 mol) in glacial acetic acid (4 mL) was taken in a two 
necked RB flask fitted with reflux condenser and guard tube. To this, an acetic anhydride (6 mL) was added slowly 
through dropping funnel with swirling. The reaction mixture was refluxed on a water bath for 3-4 hr. The progress 
of the reaction was monitored by TLC. After the completion of the reaction, the mixture was poured to an ice water 
with stirring. A solid separated was filtered; the residue was washed thoroughly with cold water and dried. The 
crude solid was recrystallized from ethanol to get the products 2(a-d) in good yields. 
 
RESULTS AND DISCUSSION 
 
Ethyl 4-acetoxy-1-(4-ethoxyphenyl)-6-methoxy-2-naphthoate, 2a: Obtained from (Z)-3-(ethoxycarbonyl)-4-(4-
ethoxyphenyl)-4-(4-methoxyphenyl)but-3-enoic acid, 1a (1.92g, 0.005 mol) in 80% (1.63g) yield, mp 108-110 ºC.IR 
(Nujol, γ cm-1): 1746, 1738 (s) (ester C=O str), 1220 (s) (C-O str). 1HNMR (CDCl3): δ 1.232 (t, 3H, CH3), 1.333 (t, 
3H, CH3), 2.214 (s, 3H, CH3), 3.855 (s, 3H, OCH3), 4.101 (q, 2H, OCH2), 4.236 (q, 2H, OCH2), 6996 (dd, 2H, Ar-
H), 7.690 (dd, 2H, Ar-H), 7.006-7.482 (m, 4H, Ar-H). 13C NMR (CDCl3): δ14.12 (1C, CH3), 14.70 (1C, CH3), 20.14 
(1C, COCH3), 55.80 (1C, OCH3), 61.22 (1C, OCH2), 64.10 (1C, OCH2), 100.13 (1C, C-8), 114.42 (2C, 3’,5’-C), 
119.24(1C, C-6), 119.87 (1C, C-2), 123.22 (1C, C-3), 128.09 (1C, C-4a), 128.78 (1C, 1’-C), 129.26 (1C, C-5), 
129.72 (2C, 2’,6’-C), 131.44 (1C, C-8a), 138.78 (1C, C-4), 142.30 (1C, C-1), 157.36 (1C, 4’-C), 160.08 (1C, C-7), 
168.42 (1C, COO), 172.01 (1C, OCO). MS (m/z): 408 (M+). Anal. Calcd. for C24H24O6: C, 70.57; H, 5.92%; Found: 
C, 70.38; H, 5.74%. 
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4.2.2. Ethyl 4-acetoxy-1-(4-ethoxyphenyl)-6,7-dimethoxy-2-naphthoate, 2b: Obtained from (E)-4-(3,4-
dimethoxyphenyl)-3-(ethoxycarbonyl)-4-(4-ethoxyphenyl)but-3-enoic acid, 1b (2.07g, 0.005 mol) in 78% (1.70g) 
yield, mp 93-94 ºC. IR (Nujol, γ cm-1): 1748, 1737 (s) (ester C=O str), 1212 (s) (C-O str). 1HNMR (CDCl3): δ 1.290 
(t, 3H, CH3), 1.325 (t, 3H, CH3), 2.237 (s, 3H, CH3), 3.852 (s, 6H, OCH3), 4.116 (q, 2H, OCH2), 4.272 (q, 2H, 
OCH2), 7.016 (dd, 2H, Ar-H), 7.682 (dd, 2H, Ar-H), 7.316-7.389 (m, 3H, Ar-H). 13C NMR (CDCl3): δ14.20 (1C, 
CH3), 14.66 (1C, CH3), 20.36 (1C, COCH3), 55.96 (2C, OCH3), 61.09 (1C, OCH2), 64.33 (1C, OCH2), 100.10 (1C, 
C-8), 106.20(1C, C-5), 114.40 (2C, 3’,5’-C), 119.02 (1C, C-2), 123.20 (1C, C-3), 127.40 (1C, C-8a), 128.24 (1C, 1’-
C), 129.65 (2C, 2’,6’-C), 131.12 (1C, C-4a), 138.63 (1C, C-4), 142.44 (1C, C-1), 149.29 (1C, C-6), 152.18 (1C, C-
7), 157.74 (1C, 4’-C), 168.33 (1C, COO), 172.36 (1C, OCO). MS (m/z): 438 (M+). Anal. Calcd. for C25H26O7: C, 
68.48; H, 5.92%; Found: C, 68.26; H, 5.75%. 
 
4.2.3. Ethyl 4-acetoxy-6,7-dimethoxy-1-(4-methoxyphenyl)-2-naphthoate, 2c: Obtained from (E)-4-(3,4-
dimethoxyphenyl)-3-(ethoxycarbonyl)-4-(4-methoxyphenyl)but-3-enoic acid, 1c (2.00g, 0.005 mol) in 82% (1.73g) 
yield, mp 101-104 ºC. IR (Nujol, γ cm-1): 1747, 1739 (s) (ester C=O str), 1208 (s) (C-O str). MS (m/z): 424 (M+). 
Anal. Calcd. for C24H24O7: C, 67.91; H, 5.70%; Found: C, 67.80; H, 5.56%. 
 
4.2.4. Ethyl 4-acetoxy-7-methoxy-1-(4-methoxyphenyl)-2-naphthoate, 2d: Obtained from (E)-3-(ethoxycarbonyl)-
4-(3-methoxyphenyl)-4-(4-methoxyphenyl)but-3-enoic acid, 1d (1.85g, 0.005 mol) in 85% (1.67g) yield, mp 109-
112 ºC.IR (Nujol, γ cm-1): 1748, 1736 (s) (ester C=O str), 1226 (s) (C-O str). 1HNMR (CDCl3): δ 1.280 (t, 3H, CH3), 
2.271 (s, 3H, CH3), 3.852 (s, 6H, OCH3), 4.288 (q, 2H, OCH2), 7.112 (dd, 2H, Ar-H), 7.656 (dd, 2H, Ar-H), 7.213-
7.542 (m, 4H, Ar-H). 13C NMR (CDCl3): δ14.55 (1C, CH3), 20.65 (1C, COCH3), 55.85 (2C, OCH3), 60.89 (1C, 
OCH2), 106.26(1C, C-5), 114.68 (2C, 3’,5’-C), 119.93 (1C, C-2), 121.10 (1C, C-8), 122.10 (1C, C-7), 126.21 (1C, 
C-3), 127.06 (1C, C-8a), 128.22 (1C, 1’-C), 129.98 (2C, 2’,6’-C), 134.10 (1C, C-4a), 138.23 (1C, C-4), 144.40 (1C, 
C-1), 157.67 (1C, 4’-C), 157.29 (1C, C-6), 168.30 (1C, COO), 171.86 (1C, OCO).MS (m/z): 394 (M+). Anal. Calcd. 
for C23H22O6: C, 70.04; H, 5.62%; Found: C, 69.86; H, 5.48%. 
 
4.3. General procedure for the synthesis of Ethyl 1-aryl-4-hydroxy-2-naphthoates, 4(a-d):(Z)-3-(Ethoxycarbonyl)-
4,4-(diaryl)but-3-enoic acids, 1(a-d) (0.005 mol) was slowly added to the freshly prepared PPA at 80 ºC with 
swirling, the mixture was stirred for another 15 min. The mixture was vigorously stirred for 3 hr on an oil bath at 90-
100 ºC. The progress of the reaction was monitored by TLC. After the completion of the reaction, the mixture was 
cooled to room temperature and was poured into ice (250g) with stirring. The dark grey-colored precipitate formed 
was filtered. The residue is digested with 10% sodium hydroxide (100 mL) for half an hour using mechanical stirrer 
and filtered again. The solid obtained was repeatedly washed with water to free alkali and then recrystallized from 
alcohol to get the products 4(a-d) in good yields. 
 
4.3.1. Ethyl 1-(4-ethoxyphenyl)-4-hydroxy-6-methoxy-2-naphthoate, 4a: Obtained from (Z)-3-(ethoxycarbonyl)-4-
(4-ethoxyphenyl)-4-(4-methoxyphenyl)but-3-enoic acid, 1a (1.92g, 0.005 mol) in 92% (1.68g) yield, mp 121-123 
ºC.IR (Nujol, γ cm-1): 3615 (sh) (OH str), 1739 (s) (ester C=O str), 1217 (s) (C-O str). 1HNMR (CDCl3): δ 1.235 (t, 
3H, CH3), 1.318 (t, 3H, CH3), 3.846 (s, 3H, OCH3), 4.022 (q, 2H, OCH2), 4.290 (q, 2H, OCH2), 5.370 (s, 1H, OH), 
6.988-7.751 (m, 8H, Ar-H).13C NMR (CDCl3): δ14.15 (1C, CH3), 14.82 (1C, CH3), 55.82 (1C, OCH3), 61.26 (1C, 
OCH2), 63.78 (1C, OCH2), 100.20 (1C, C-8), 110.12 (1C, C-2), 114.40 (2C, 3’,5’-C), 119.34 (1C, C-6), 123.94 (1C, 
C-3), 127.04 (1C, C-5), 128.48 (1C, C-8a), 128.74 (1C, 1’-C), 129.10 (2C, 2’,6’-C), 129.72 (1C, C-4a), 133.22 (1C, 
C-4), 151.56 (1C, C-1), 157.86 (1C, 4’-C), 159.23 (1C, C-7), 168.50 (1C, COO).MS (m/z): 366 (M+). Anal. Calcd. 
for C22H22O5: C, 72.12; H, 6.05%; Found: C, 71.92; H, 5.92%. 
 
4.3.2. Ethyl 1-(4-ethoxyphenyl)-4-hydroxy-6,7-dimethoxy-2-naphthoate, 4b: Obtained from (E)-4-(3,4-
dimethoxyphenyl)-3-(ethoxycarbonyl)-4-(4-ethoxyphenyl)but-3-enoic acid, 1b (2.07g, 0.005 mol) in 86% (1.70g) 
yield, mp 113-115 ºC. IR (Nujol, γ cm-1): 3622 (sh) (OH str), 1738 (s) (ester C=O str), 1221 (s) (C-O str). 1HNMR 
(CDCl3): δ 1.260 (t, 3H, CH3), 1.321 (t, 3H, CH3), 3.850 (s, 6H, OCH3), 4.130 (q, 2H, OCH2), 4.302 (q, 2H, OCH2), 
5.388 (s, 1H, OH), 6.992-7.760 (m, 7H, Ar-H). 13C NMR (CDCl3): δ14.10 (1C, CH3), 14.76 (1C, CH3), 55.45 (2C, 
OCH3), 61.08 (1C, OCH2), 63.87 (1C, OCH2), 100.34 (1C, C-8), 105.23 (1C, C-5), 110.06 (1C, C-2), 114.45 (2C, 
3’,5’-C), 124.31 (1C, C-8a), 124.80 (1C, C-3), 128.70 (1C, 1’-C), 129.30 (2C, 2’,6’-C), 130.77 (1C, C-4a), 133.20 
(1C, C-4), 150.34 (1C, C-6), 151.51 (1C, C-1), 153.20 (1C, C-7), 157.82 (1C, 4’-C), 168.44 (1C, COO).MS (m/z): 
396 (M+). Anal. Calcd. for C23H24O6: C, 69.68; H, 6.10%; Found: C, 69.53; H, 5.93%. 
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4.3.3. Ethyl 4-hydroxy-6,7-dimethoxy-1-(4-methoxyphenyl)-2-naphthoate, 4c: Obtained from (E)-4-(3,4-
dimethoxyphenyl)-3-(ethoxycarbonyl)-4-(4-methoxyphenyl)but-3-enoic acid, 1c (2.00g, 0.005 mol) in 90% (1.71g) 
yield, mp 115-117 ºC.IR (Nujol, γ cm-1): 3630 (sh) (OH str), 1736 (s) (ester C=O str), 1112 (s) (C-O str).MS (m/z): 
382 (M+). Anal. Calcd. for C22H22O6: C, 69.01; H, 5.80%; Found: C, 69.10; H, 5.71%. 
 
4.3.4. Ethyl 4-hydroxy-7-methoxy-1-(4-methoxyphenyl)-2-naphthoate, 4d: Obtained from (E)-3-(ethoxycarbonyl)-
4-(3-methoxyphenyl)-4-(4-methoxyphenyl)but-3-enoic acid, 1d (1.85g, 0.005 mol) in 83% (1.46g) yield, mp 128-
129 ºC.IR (Nujol, γ cm-1): 3635  (sh) (OH str), 1748 (s) (ester C=O str), 1226 (s) (C-O str). 1HNMR (CDCl3): δ 
1.286 (t, 3H, CH3), 3.860 (s, 6H, OCH3), 4.282 (q, 2H, OCH2), 5.404 (s, 1H, OH), 7.012-7.760 (m, 8H, Ar-H).13C 
NMR (CDCl3): δ14.33 (1C, CH3), 55.85 (2C, OCH3), 60.84 (1C, OCH2), 106.35 (1C, C-5), 109.02 (1C, C-2), 
114.56 (2C, 3’,5’-C), 120.20 (1C, C-7), 121.36 (1C, C-8), 124.40 (1C, C-8a), 125.90 (1C, C-3), 128.44 (1C, 1’-C), 
129.89 (2C, 2’,6’-C), 133.20 (1C, C-4), 135.66 (1C, C-4a), 152.52 (1C, C-1), 158.10 (1C, C-6), 158.46 (1C, 4’-C), 
168.22 (1C, COO). MS (m/z): 352 (M+). Anal. Calcd. for C21H20O5: C, 71.58; H, 5.72%; Found: C, 71.43; H, 
5.61%. 
 
Structure proofs of the synthesized new compounds 2(a-d) and 4(a-d) were provided by IR, 1H NMR, 13C NMR, 
MS studies and elemental analysis. In IR spectra, the stretching frequencies for the compounds 2(a-d) showed a 
strong absorption band in the region 1746-1735 cm-1for ester C=O bonds. A strong and intense absorption band is 
absorbed in the region of 1225-1208 cm-1 was assigned to C-O bonds. 
 
The structural analysis of the compounds 2(a-d) were made by 1H NMR and 13C NMR spectral studies by 
considering ethyl 4-acetoxy-6,7-dimethoxy-1-(4-methoxyphenyl)-2-naphthoate, 2c as the representative compound. 
In its 1H NMR spectra, 2c showed a singlet at δ 2.258,δ 3.860, triplet at δ 1.286, and a quartet at δ 4.290 ppm. were 
assigned to acetoxy CH3,  OCH3, ester CH3 and OCH2 protons respectively. An array of signals appeared as 
multiplet in the region δ 7.108-7.674 ppm. for seven protons were assigned to aromatic protons. The compounds 4a, 
4b and 4c showed similar consistent pattern signals in their 1H NMR spectra. 
 
In its 13C NMR spectra, the compound 2c showed the signals at δ 168.55 and δ 172.73 ppm. for ester and acetoxy 
carbonyl carbons respectively. The signals observed at δ 14.27, 20.53, 55.85 and 61.10 ppm. were assigned to ester 
CH3, acetoxy CH3, OCH3 and ester OCH2 carbons. The acetoxy function on C-1 carbon deshielded its signal to a 
downfield of δ 142.81 ppm. The other carbon chemical shifts of compound 2c were depicted in fig-1. The 
compounds 2a, 2b and 2d showed similar consistent pattern signals in their 13C NMR spectra. 
 
 
The stretching frequencies in the IR spectrum of the compounds 4(a-d) showed a sharp absorption band in the 
region of γ 3635-3618cm-1 for phenolic –OH and a strong absorption bands in the region 1748-1736 cm-1 for ester 
C=O bonds. A strong and intense absorption band is absorbed in the region 1226-1112 cm-1 was assigned to C-O 
bonds. 
 
The structural analysis of the compounds 4(a-d) were made by 1H NMR and 13C NMR spectral studies by 
considering ethyl 4-hydroxy-6,7-dimethoxy-1-(4-methoxyphenyl)-2-naphthoate, 4c as the representative compound. 
In its 1H NMR spectra, 4c showed a signal due to phenolic –OH proton as singlet at δ 5.370 ppm. An array of 
signals appeared as multiplet in the region δ 6.978-7.526 ppm. for seven protons were assigned to aromatic protons. 
An intense singlet and a triplet appeared at δ 3.858 ppm. for nine protons and at δ 1.242 ppm. for three protons were 
assigned to three –OCH3 protons and ester CH3 protons respectively. Further, a quartet appeared at δ 4.230 ppm. for 
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two protons was assigned to ester –OCH2 protons. The compounds 4a, 4b and 4c showed similar consistent pattern 
signals in their 1H NMR spectra. 
 
In its 13C NMR spectra, the compound 4c showed the signal at δ 168.50 ppm. for ester carbonyl carbons. The signals 
observed at δ 14.15, 55.88 and 61.26 ppm. were assigned to CH3, OCH3 and OCH2 carbons. The –OH function on 
C-1 carbon deshielded its signal to a downfield at δ 150.56 ppm. The carbon chemical shifts of compound 4c were 
depicted in fig-2. The compounds 4a, 4b and 4d showed similar consistent pattern signals in their 13C NMR spectra. 
 
 
 
All the synthesized compounds 2(a-d) and 4(a-d) showed stable molecular mass peaks with their respective M+ ion 
peak as base peaks. Further their structures were supported by satisfactory elemental analysis. 
 
Antimicrobial activity of the synthesized compounds was done by paper disc diffusion method [9-11]. The test 
compounds 2(a-d) and 4(a-d) at the concentration of 50 µg/mL in methanol in the nutrient agar media were 
screened for their antibacterial activity against bacteria species Escherichia coli, Bacillus substilis, Staphylococus 
aureus and antifungal activity against fungal species Aspergillus niger, Aspergillus flavus, Fusarium oxysporium. 
The antibiotics ciprofloxacin and nystatin were used as standard drugs against bacteria and fungi species 
respectively. The screening tests were carried out in triplicate and the results were expressed as a mean of three 
determinations. 
The results of antibacterial activity of the synthesized compounds 2(a-d) and 4(a-d) tested against different bacteria 
species were summarized in fig 3. 
 
. 
 
The antibacterial activity results of the synthesized compounds 2(a-d) and 4(a-d) revealed that all compounds 
exerted moderate to excellent activity against the tested organisms, except ethyl 4-acetoxy-1-(4-ethoxyphenyl)-6-
methoxy-2-naphthoate 2a, that contain para substitutions on both the aromatic ring showed poor inhibition against 
all the tested organisms. The compounds 2b, 2c, 4b and 4c which contain 3,4-dimethoxy and 4-ethoxy substitutions 
showed excellent activity in comparison with the standard. The compounds 2d, 4a and 4d showed moderate 
inhibition against the tested bacterial strains.  
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The results of antifungal activity of the synthesized compounds 2(a-d) and 4(a-d) tested against different fungi 
species were summarized in fig 4. 
 
. 
 
From the antifungal activity results, it was observed that compounds 2(a-d) and 4(a-d) showed lesser inhibition 
effect against F. oxysporium organism. The compounds 2b, 2c, 4b and 4c having 3,4-dimethoxy and 4-ethoxy 
substitutions in the aromatic ring showed a greater inhibition against  A. niger and A. flavus organisms. Against the 
organisms A. niger and A. flavus, the compounds 2d, 4d and 2a,4a showed moderate and lesser inhibition 
respectively comparison with that of the standard drug. 
 
CONCLUSION 
 
The easy and accessible procedure for the synthesis of ethyl 4-acetoxy-1-aryl-2-naphthoates, 2(a-d) and ethyl 1-aryl-
4-hydroxy-2-naphthoates, 4(a-d) from 4,4-diaryl-3-ethoxycarbonyl-but-3-enoic acids was described. The 
synthesized compounds were screened for their inhibitory effect on bacteria and fungi strains. The efficacy of the 
synthesized compounds 2b, 2c, 4b and 4d as potential antifungal and antibacterial agents validates the significance 
of this study.  
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